Inovio Pharmaceuticals
INO
INO
113 hedge funds and large institutions have $26.2M invested in Inovio Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 32 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
28% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 32
40% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 25
Holders
113
Holding in Top 10
–
Calls
$313K
Puts
$29K
Top Buyers
| 1 | +$1.78M | |
| 2 | +$1.23M | |
| 3 | +$397K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$218K |
| 5 |
Amundi
Paris,
France
|
+$120K |
Top Sellers
| 1 | -$2.12M | |
| 2 | -$1.44M | |
| 3 | -$1.01M | |
| 4 |
GC
GMT Capital
Atlanta,
Georgia
|
-$589K |
| 5 |
Two Sigma Investments
New York
|
-$255K |